The introduction of new pharmaceutical veterinary products is dependent on a wide range of activities, through development and manufacturing to clinical field trials and building the regulatory dossier. A key activity, and the focus of John W Banks of Triveritas`s article, is the transfer of the process development knowledge into a cGMP manufacturing facility to generate formulated products that can be used in either clinical or commercial supply.